InsiderInsights.com Daily Ratings Report: April 19, 2024
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Harrow Health focuses on the development, production and sale of medications. The company mainly focuses on its ImprimisRx business, which is an ophthalmology pharmaceutical compounding business, and Park Compounding, Inc., which is a pharmacy focused primarily on health and wellness related, customizable pharmaceutical compounding. The company's other subsidiaries include: Eton Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products utilizing the U.S. Food and Drug Administration 505(b)(2) regulatory pathway; and Surface Pharmaceuticals, Inc., a pharmaceutical company focused on development and commercialization of therapeutics for ocular surface diseases.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.